Analysis Reveals 'Female Libido' Pill May Not Be Worth It

This article originally appeared here.
Share this content:
Analysis Reveals 'Female Libido' Pill May Not Be Worth It
Analysis Reveals 'Female Libido' Pill May Not Be Worth It

MONDAY, Feb. 29, 2016 (HealthDay News) -- Flibanserin (Addyi), the "female libido" pill, appears to cause many serious side effects while failing to increase the desire for sexual activity, according to a review published online Feb. 29 in JAMA Internal Medicine.

Ellen Laan, Ph.D., professor of sexology and psychosomatic gynecology at the University of Amsterdam, and colleagues reviewed eight clinical trials conducted with flibanserin, including five published and three unpublished studies involving 5,914 women.

The combined evidence showed that flibanserin provides marginal benefit for women who are suffering hypoactive sexual desire disorder. For example, women taking the medication scored just 0.3 points higher on a 5-point sexual desire scale and experienced a minimal increase in satisfying sexual events each month, the review authors found. But flibanserin also quadruples the risk of dizziness and sleepiness, more than doubles the chances of nausea, and increases the risk of fatigue by more than half, according to the analysis.

"We found women had, on average, 2.5 satisfying sexual events per month before entering the study, and flibanserin added one-half additional satisfying sexual events per month," Laan told HealthDay.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »